USF Researcher Stands on Forefront of Health Breakthrough
Ellen Daley, PhD, is living a researcher’s dream. She and her colleagues stand on the forefront of a veritable medical milestone and a major public health initiative — a newly approved vaccine that will prevent the certain strains of cancer-causing HPV and, in turn, can virtually eradicate cervical cancer.
“The Food and Drug Administration’s approval was great news! This is a grand slam,” said Daley of the FDA’s June 8 approval of Merck’s HPV vaccine, Gardasil. “This kind of breakthrough should go down with other medical milestones, like the polio vaccine, and antibiotics.”
Dr. Daley’s research on the psychosocial aspects of HPV, or human papilloma virus, have been federally funded by the Centers for Disease Control and Prevention and the National Cancer Institute.
